Curcumin Induces Cell Death in Human Uveal Melanoma Cells through Mitochondrial Pathway

REFERENCES

• Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–1693.
   PubMedGoogle Scholar
• Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269:199–225.
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: A short review. Life Sci. 2006;78:2081–2087.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003;23:363–398.
   PubMed Web of Science ®Google Scholar
• Dorai T, Cao YC, Dorai B, et al. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47:293–303.
   PubMed Web of Science ®Google Scholar
• Moragoda L, Jaszewski R, Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res. 2001;21:873–878.
   PubMed Web of Science ®Google Scholar
• Anto RJ, Mukhopadhyay A, Denning K, et al. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis. 2002;23:143–150.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Ghosh U, Bhattacharyya NP, et al. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res. 2006;596:81–90.
   PubMed Web of Science ®Google Scholar
• Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene. 2006;25:278–287.
   PubMed Web of Science ®Google Scholar
• Dorai T, Gehani N, Katz A. Therapeutic potential of curcumin in human prostate cancer—I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis. 2000;3:84–93.
   PubMed Web of Science ®Google Scholar
• Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta. 1996;1317:95–100.
   PubMed Web of Science ®Google Scholar
• Shi M, Cai Q, Yao L, et al. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int. 2006;30:221–226.
   PubMed Web of Science ®Google Scholar
• Huang MT, Lou YR, Ma W, et al. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994;54:5841–5847.
   PubMed Web of Science ®Google Scholar
• Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999;59:597–601.
   PubMed Web of Science ®Google Scholar
• Rao CV, Rivenson A, Simi B, et al. Chemoprevention of colon cancer by dietary curcumin. Ann N Y Acad Sci. 1995;768:201–204.
   PubMed Web of Science ®Google Scholar
• Li N, Chen X, Liao J, et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23:1307–1313.
   PubMed Web of Science ®Google Scholar
• Chuang SE, Kuo ML, Hsu CH, et al. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000;21:331–335.
   PubMed Web of Science ®Google Scholar
• Inano H, Onoda M, Inafuku N, et al. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis. 1999;20:1011–1018.
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Lipigorngoson S, Namwong O, et al. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett. 1997;116:197–203.
   PubMed Web of Science ®Google Scholar
• Azuine MA, Bhide SV. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer. 1992;17:77–83.
   PubMed Web of Science ®Google Scholar
• Hong JH, Ahn KS, Bae E, et al. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 2006;9:147–152.
   PubMed Web of Science ®Google Scholar
• Strimpakos AS, Sharma RA. Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008;10:511–545.
   PubMed Web of Science ®Google Scholar
• Bush JA, Cheung KJ Jr, Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res. 2001;271:305–314.
   PubMed Web of Science ®Google Scholar
• Odot J, Albert P, Carlier A, et al. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer. 2004;111:381–387.
   PubMed Web of Science ®Google Scholar
• Bakhshi J, Weinstein L, Poksay KS, et al. Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: Effect of curcumin. Apoptosis. 2008;13:904–914.
   Google Scholar
• Purkayastha S, Berliner A, Fernando SS, et al. Curcumin blocks brain tumor formation. Brain Res. 2009;1266:130–138.
   PubMed Web of Science ®Google Scholar
• Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compound. Cancer Lett. 1995;95:221–225.
   PubMed Web of Science ®Google Scholar
• Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–1348.
   PubMed Web of Science ®Google Scholar
• Bergman L, Seregard S, Nilsson B, et al. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579–2583.
   PubMed Web of Science ®Google Scholar
• Yu GP, Hu DN, McCormick SA. Latitude and incidence of ocular melanoma. Photochem Photobiol. 2006;82:1621–1626.
   PubMed Web of Science ®Google Scholar
• Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445:851–857.
   PubMed Web of Science ®Google Scholar
• Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003;3:559–570.
   PubMed Web of Science ®Google Scholar
• Spendlove HE, Damato BE, Humphreys J, et al. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 2004;14:449–452.
   PubMed Web of Science ®Google Scholar
• Cruz F 3rd, Rubin BP, Wilson D, et al. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res. 2003;63:5761–5766.
   Google Scholar
• Vajdic CM, Hutchins AM, Kricker A, et al. Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study. Cancer Genet Cytogenet. 2003;144:12–17.
   PubMed Web of Science ®Google Scholar
• Thompson FH, Emerson J, Olson S, et al. Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet. 1995;83:93–104.
   PubMed Web of Science ®Google Scholar
• Sisley K, Tattersall N, Dyson M, et al. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Exp Eye Res. 2006;83:554–559.
   PubMed Web of Science ®Google Scholar
• Hu DN, Yu G, McCormick SA, et al. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol. 2008;145:418–423.
   PubMed Web of Science ®Google Scholar
• Hu DN, McCormick SA, Ritch R, et al. Studies of human uveal melanocytes in vitro: Isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci. 1993;33:2210–2219.
   Google Scholar
• Hu DN, McCormick SA. Biochemical pathways: Different gene expression and cellular pathways determining tumor phenotype comparison of uveal melanocytes and uveal melanoma cells in vitro. In: DM Albert, A. Polans (Eds.). Ocular Oncology. New York, NY: Marcel Dekker; 2003; pp. 189–210.
   Google Scholar
• Soulieres D, Rousseau A, Deschenes J, et al. Characterization of gangliosides in human uveal melanoma cells. Int J Cancer. 1991;49:498–503.
   PubMed Web of Science ®Google Scholar
• Anand P, Sundaram C, Jhurani S, et al. Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett. 2008;267:133–164.
   PubMed Web of Science ®Google Scholar
• Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57:1–7.
   PubMed Web of Science ®Google Scholar
• Conney AH. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: The Seventh DeWitt S. Goodman Lecture. Cancer Res. 2003;63:7005–7031.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Farmer PB. Biological relevance of adduct detection to the chemoprevention of cancer. Clin Cancer Res. 2004;10:4901–4912.
   PubMed Web of Science ®Google Scholar
• Menon LG, Kuttan R, Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett. 1999;141:159–165.
   PubMed Web of Science ®Google Scholar
• Rao CV, Rivenson A, Simi B, et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995;55:259–266.
   PubMed Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, et al. Phase II clinical trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491–4499.
   PubMed Web of Science ®Google Scholar
• Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: From kitchen to clinic. Biochem Pharmacol. 2008;75:787–809.
   PubMed Web of Science ®Google Scholar
• Roberts JE, Wiechmann AF, Hu DN. Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res. 2000;28:165–171.
   PubMed Web of Science ®Google Scholar
• Lu F, Yan D, Zhou X, et al. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells. Mol Vis. 2007;13:2066–2072.
   PubMed Web of Science ®Google Scholar
• Ye M, Hu DN, Tu L, et al. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci. 2008;49:497–504.
   PubMed Web of Science ®Google Scholar
• Yan D, Zhou X, Chen X, et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci. 2009;50:1559–1565.
   PubMed Web of Science ®Google Scholar
• Hu DN, Wakamatsu K, Ito S, et al. Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes. Melanoma Res. 2009;19:75–79.
   Google Scholar
• Green DR. Apoptotic pathways: Ten minutes to dead. Cell. 2005;121:671–674.
   PubMed Web of Science ®Google Scholar
• Pal S, Choudhuri T, Chattopadhyay S, et al. Mechanisms of curcumin-induced apoptosis of Ehrlich’s ascites carcinoma cells. Biochem Biophys Res Commun. 2001;288:658–665.
   PubMed Web of Science ®Google Scholar
• Morin D, Barthelemy S, Zini R, et al. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett. 2001;495:131–136.
   PubMed Web of Science ®Google Scholar
• Su CC, Lin JG, Li TM, et al. Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 2006;26:4379–4389.
   PubMed Web of Science ®Google Scholar
• Tan TW, Tsai HR, Lu HF, et al. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation. Anticancer Res. 2006;26:4361–4371.
   PubMed Web of Science ®Google Scholar
• Kim CN, Wang X, Huang Y, et al. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 1997;57:3115–3120.
   PubMed Web of Science ®Google Scholar
• Pan MH, Chang WL, Lin-Shiau SY, et al. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem. 2001;49:1464–1474.
   PubMed Web of Science ®Google Scholar
• Khar A, Ali AM, Pardhasaradhi BV, et al. Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett. 1999;445:165–168.
   PubMed Web of Science ®Google Scholar
• Mandal MN, Patlolla JM, Zheng L, et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 2009;46:672–679.
   PubMed Web of Science ®Google Scholar
• Pandya U, Saini MK, Jin GF, et al. Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicol Lett. 2000;115:195–204.
   PubMed Web of Science ®Google Scholar
• Rema M, Pradeepa R. Diabetic retinopathy: An Indian perspective. Indian J Med Res. 2007;125:297–310.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330:155–163.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: Problems and promises. Mol Pharm. 2007;4:807–818.
   PubMed Web of Science ®Google Scholar
• Mosley CA, Liotta DC, Snyder JP. Highly active anticancer curcumin analogues. Adv Exp Med Biol. 2007;595:77–103.
   PubMed Web of Science ®Google Scholar